Enhanced antitumor effect of the combination of Bacille Calmette-Guerin and an immune checkpoint inhibitor in bladder cancer-on-a-chip

被引:0
|
作者
Choi, S. Y. [1 ]
Tae, J. H. [1 ]
Chi, B. H. [1 ]
Chang, I. H. [1 ]
T.-H, Kim [1 ]
Myung, S. C. [1 ]
Kim, J. H. [2 ]
Kim, J. W. [2 ]
Lee, Y. S. [2 ]
机构
[1] Chung Ang Univ, Chung Ang Univ Hosp, Dept Urol, Coll Med, Seoul, South Korea
[2] Chung Ang Univ, Chung Ang Univ Gwangmyeong Hosp, Dept Urol, Coll Med, Gwangmyeong, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A0425
引用
收藏
页码:S610 / S610
页数:1
相关论文
共 50 条
  • [31] Predictive value of immunological markers after bacille Calmette-Guerin induction in bladder cancer
    Elsawy, Amr A.
    Abol-Enein, Hassan
    Laymon, Mahmoud
    Ahmed, Asmaa E.
    Essam, Ahmed
    Hamam, Eman T.
    Zidan, Abdel-Aziz A.
    Zahran, Mohamed H.
    Shokeir, Ahmed A.
    Awadalla, Amira
    BJU INTERNATIONAL, 2022, 130 (04) : 444 - 453
  • [32] Cancer-on-a-Chip for Modeling Immune Checkpoint Inhibitor and Tumor Interactions
    Jiang, Xing
    Ren, Li
    Tebon, Peyton
    Wang, Canran
    Zhou, Xingwu
    Qu, Moyuan
    Zhu, Jixiang
    Ling, Haonan
    Zhang, Shiming
    Xue, Yumeng
    Wu, Qingzhi
    Bandaru, Praveen
    Lee, Junmin
    Kim, Han-Jun
    Ahadian, Samad
    Ashammakhi, Nureddin
    Dokmeci, Mehmet R.
    Wu, Jinhui
    Gu, Zhen
    Sun, Wujin
    Khademhosseini, Ali
    SMALL, 2021, 17 (07)
  • [33] Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer
    Böhle, A
    Brandau, S
    JOURNAL OF UROLOGY, 2003, 170 (03): : 964 - 969
  • [34] INTRAVESICAL BACILLE CALMETTE-GUERIN (BCG) FOR BLADDER-CANCER - REQUIREMENT OF FIBRONECTIN-MEDIATED BCG ATTACHMENT FOR AN ANTITUMOR RESPONSE
    RATLIFF, TL
    KAVOUSSI, LR
    RITCHEY, JK
    BROWN, EJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 413 - 413
  • [35] Gemcitabine Versus Bacille Calmette-Guerin After Initial Bacille Calmette-Guerin Failure in Non-Muscle-Invasive Bladder Cancer: A Multicenter Prospective Randomized Trial Editorial Comment
    Montie, James E.
    JOURNAL OF UROLOGY, 2011, 185 (01): : 101 - 102
  • [36] SEROPOSITIVE GENERALIZED MYASTHENIA GRAVIS FOLLOWING INTRAVESICAL BACILLE CALMETTE-GUERIN TREATMENT FOR BLADDER CANCER
    Shah, Jaimin
    Kushlaf, Hani
    MUSCLE & NERVE, 2014, 50 (04) : 704 - 704
  • [37] Diminished Efficacy of Bacille Calmette-Guerin Among Elderly Patients with Nonmuscle Invasive Bladder Cancer
    Margel, David
    Alkhateeb, Sultan S.
    Finelli, Antonio
    Fleshner, Neil
    UROLOGY, 2011, 78 (04) : 848 - 854
  • [38] Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guerin
    Packiam, Vignesh T.
    Johnson, Scott C.
    Steinberg, Gary D.
    CANCER, 2017, 123 (03) : 390 - 400
  • [39] Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-GuErin
    Gee, Jason R.
    Jarrard, David F.
    Bruskewitz, Reginald C.
    Moon, Timothy D.
    Hedican, Sean P.
    Leverson, Glen E.
    Nakada, Stephen Y.
    Messing, Edward M.
    BJU INTERNATIONAL, 2009, 103 (06) : 736 - 739
  • [40] Intravesical Bacille Calmette-Guerin Eradicates Bacteriuria in Antibiotic-naive Bladder Cancer Patients
    Herr, Harry W.
    EUROPEAN UROLOGY, 2013, 63 (05) : 832 - 835